Viatris (2)
China - Shanghai
253 open jobs
MAFENIDE ACETATE (mafenide acetate) by Viatris (2) is clinical pharmacology sulfamylon cream, applied topically produces a marked reduction in the bacterial population present in the avascular tissues of second- and third-degree burns. First approved in 2017.
Drug data last refreshed 1w ago
CLINICAL PHARMACOLOGY SULFAMYLON Cream, applied topically produces a marked reduction in the bacterial population present in the avascular tissues of second- and third-degree burns. Reduction in bacterial growth after application of SULFAMYLON Cream has also been reported to permit spontaneous…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Worked on MAFENIDE ACETATE at Viatris (2)? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.